Digital Pathology & AI

AI in tissue analysis: computational pathology, histology interpretation, and automated cancer grading.

Why it matters: Pathology faces a workforce shortage. AI assistants can help pathologists analyze slides faster while maintaining diagnostic accuracy.

7 research items

Get updates on this topic

Sort by Date Sort by Relevance

From: 2026-10-31

ArXiv - Quantitative BiologyPromising2 min read

AI model speeds up HER2 breast cancer testing

Key Takeaway:

An AI model can predict HER2 status from standard breast cancer microscopy slides nearly as accurately as pathologists, potentially speeding decisions on targeted therapy eligibility within two to five years.

Breast cancer patients often need a test called HER2 to see if they qualify for special drugs that target their cancer. Doctors currently use a microscope and a scoring system—but tricky middle-ground cases require extra testing that takes weeks. Researchers built an artificial intelligence system trained on thousands of cancer slides to predict HER2 status automatically from routine pictures. When tested in three hospitals, it performed nearly as well as expert pathologists and was much faster—just 5–6 seconds per slide. The tool isn't replacing doctors yet, but it could help speed up which patients get the extra confirmation test, potentially getting people treated sooner.

What this means for you

Researchers built an AI tool to help pathologists identify HER2 status faster from routine cancer slides, potentially reducing wait times for treatment decisions. Still experimental; not yet used in standard care.

Diagnostic AI Oncology Pathology

Citation:

ArXiv, 2026. arXiv: 2610.40662 Read article →

Guideline Update

From: 2026-08-14

ArXiv - Quantitative BiologyExploratory3 min read

How Pathology AI Can Best Spot Hidden Disease Under Limited Computing Power

Key Takeaway:

Pathologists can optimize diagnostic AI by choosing between full-slide automated scans or targeted, expert-selected views based on specific lesion patterns and computational constraints.

Pathologists often use artificial intelligence to analyze high-resolution digital scans of tissue samples, but running AI on these massive images requires significant computing power. Researchers studied two ways to solve this: letting the AI scan the entire slide automatically, or having an expert human first point the AI toward key areas. They found that full-slide AI is best for finding tiny, rare abnormalities like hidden tumor spots. However, human-guided AI works better for complex tasks, such as finding infectious bugs in cluttered tissue or mapping out continuous tumors. Matching the AI tool to the specific type of disease can make digital diagnoses more efficient and accurate.

What this means for you

Researchers explored how AI tools can best assist pathologists under computing limits. This early theoretical work will not change patient care immediately, but it helps design more accurate diagnostic tools for the future.

Pathology Diagnostic AI

Citation:

ArXiv, 2026. arXiv: 2608.10846 Read article →

Safety Alert

Tomorrow’s Smart Pills Will Deliver Drugs and Take Biopsies

From: 2026-02-20

IEEE Spectrum - BiomedicalExploratory3 min read

Smart pills will soon deliver drugs and take biopsies

Key Takeaway:

Researchers have developed a 'smart pill' that can deliver medication and collect tissue samples, potentially transforming non-invasive diagnostics and treatments in the coming years.

Biomedical engineers have designed an electronic "smart pill" that can travel through the gut to deliver medication and collect tissue samples. This swallowable capsule is packed with microelectronics, allowing it to assess tissue health and perform non-invasive biopsies from inside the gastrointestinal tract. This technology could eventually replace uncomfortable procedures like endoscopies and expensive CT scans, giving doctors a patient-friendly way to diagnose and treat digestive diseases with high precision.

What this means for you

Exciting research on "smart pills" shows promise for future drug delivery and diagnostics. However, it's still early, and not available yet. Continue with your current care and consult your doctor for advice.

Pathology Clinical Trial Drug Discovery

Citation:

IEEE Spectrum - Biomedical, 2026. Read article →

Safety Alert

From: 2026-02-18

IEEE Spectrum - BiomedicalExploratory3 min read

Smart pill delivers drugs and takes biopsies inside gut

Key Takeaway:

Researchers have developed a smart pill that can deliver medication and take biopsies in the gut, potentially transforming non-invasive diagnostics and treatment in the coming years.

Engineers have designed an innovative electronic capsule that patients can swallow to diagnose and treat gut issues. Once inside the gastrointestinal tract, the smart pill can deliver targeted medication and perform complex diagnostic tasks, including assessing tissue health and collecting physical biopsies. By replacing invasive procedures that usually require sedation and carry surgical risks, this high-tech capsule could streamline gastrointestinal care and provide real-time data directly from inside the patient's body.

What this means for you

Exciting early research shows potential for smart pills to deliver drugs and take biopsies. It's not available yet, so continue with your current care plan and consult your doctor for advice.

Drug Discovery Pathology

Citation:

IEEE Spectrum - Biomedical, 2026. Read article →

Safety Alert

From: 2026-02-16

IEEE Spectrum - BiomedicalExploratory3 min read

Smart pills will soon take biopsies from inside

Key Takeaway:

Researchers have developed a smart pill that can deliver medication and take tissue samples in the gut, potentially revolutionizing diagnostics and treatment in the coming years.

Biomedical engineers have designed an electronic smart pill that can travel through the gut to deliver targeted medication and collect tissue samples. Currently, examining the digestive tract requires invasive hospital procedures under sedation. This swallowable capsule could monitor the gut in real-time, offering a comfortable way to detect early signs of gastrointestinal cancers and other diseases from home.

What this means for you

This exciting research is still in early stages and not available yet. It may take years before it's ready. Continue with your current care plan and discuss any questions with your doctor.

Pathology Clinical Trial

Citation:

IEEE Spectrum - Biomedical, 2026. Read article →

Safety Alert

From: 2026-02-13

IEEE Spectrum - BiomedicalExploratory3 min read

Tiny electronic pill delivers medicine and takes biopsies

Key Takeaway:

MIT and Brigham researchers have created a small electronic pill that can deliver drugs and take biopsies in the gut, potentially transforming diagnosis and treatment within a few years.

Engineers have created a high-tech electronic capsule, smaller than a standard multivitamin, that patients can swallow. As the pill travels autonomously through the digestive tract, it can deliver targeted doses of medication directly to diseased areas. Simultaneously, the capsule is equipped with microscopic tools and sensors that allow it to assess tissue health and even collect physical tissue biopsies from the gut wall. This innovation could soon offer a painless, non-invasive alternative to traditional procedures like endoscopies and CT scans, making early detection of gastrointestinal diseases and cancers much easier.

What this means for you

Exciting research on a tiny pill that delivers medicine and checks tissue health. It's still in early stages, so it won't be available soon. Keep following your doctor's current advice for your care.

Drug Discovery Pathology Clinical Trial

Citation:

IEEE Spectrum - Biomedical, 2026. Read article →

From: 2025-12-01

ArXiv - AI in Healthcare (cs.AI + q-bio)Exploratory3 min read

AI uses language models to improve diabetic eye screening

Key Takeaway:

Researchers have developed a new AI method that improves diabetic retinopathy diagnosis accuracy across multiple centers, potentially enhancing early treatment and vision preservation.

Scientists have created a new AI method that improves how diabetic retinopathy is diagnosed across different medical centers. Traditional AI tools look only at images of the eye, which can lead to mistakes because different hospitals use different cameras and settings. This new approach uses large language models to help the AI understand the underlying medical concepts and descriptions of the disease. By combining visual data with this deeper semantic knowledge, the AI can make highly accurate diagnoses regardless of which hospital the patient visits, helping doctors intervene early to save patient eyesight.

What this means for you

This research is promising but still in early stages. It may take years before it's available. Continue following your doctor's current recommendations for diabetic retinopathy care.

Pathology Diagnostic AI Clinical Decision ML Diagnostics

Citation:

ArXiv, 2025. arXiv: 2511.22033 Read article →

Exploring Pathology? Learn how to interpret medical AI research →